Earnings have fallen but are still strong enough to meet CVS Health's dividend commitment. Management expects adjusted ...

Our drive to greater drug pricing transparency through innovation has never been more needed,” Ed DeVaney says.

CVS Health has named Ed DeVaney as president of its pharmacy benefit manager, CVS Caremark. | DeVaney has served as interim ...

Companies inform investors of possible business risks from Trump's government changes, tucking warnings into extensive "risk ...

CVS director Mike Mahoney, whose day job is CEO of Boston Scientific, bought 30,000 shares of the healthcare company.

Ed DeVaney’s promotion is the latest leadership shakeup at CVS Health as the company works on a multi-year turnaround plan.

CVS Health® (NYSE: CVS) named Ed DeVaney president of the company's CVS Caremark pharmacy benefit management business. He was named interim president in December 2024. DeVaney will report to Prem Shah ...

Before serving as interim president at Caremark, DeVaney led sales and account management as president of employer and health ...

We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this article, we are going to ...

CVS Health (CVS) has made an impressive comeback in 2025, with its stock soaring 45% so far this year. This sharp rebound follows a tough 2024, when its shares dropped over 40% due to missed earnings ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

In the latest executive shakeup at CVS, the pharmacy giant has named a new president of its pharmacy benefit management ...